Skin Abnormalities clinical trials
The registry lists 39 studies for Skin Abnormalities across more than 10 countries. 7 are recruiting or about to start. 20 of them are mainly about Skin Abnormalities (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-19. Counting its 20 narrower conditions too, such as Neurofibromatosis 1: 908 studies, 212 open.
Get an email when these change. Save the Skin Abnormalities studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Pulse Biosciences, Inc. (3) · BioMendics, LLC (2) · Enspectra Health (2) · University of North Carolina, Charlotte (1) · University of Miami (1) · Healthpoint (1) · Hillel Yaffe Medical Center (1) · Bend Beauty Inc. (1)
What is being tested here
Drugs under test in Skin Abnormalities studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Botulinum toxin type A | 1 | 0 | 1 |
| Episalvan | 1 | 1 | 1 |
| Birch triterpenes | 1 | 1 | 1 |
| Deoxycholic Acid | 0 | 0 | 1 |
| Tea | 0 | 0 | 1 |
| Phlebodium aureum | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2
- Jan 2027A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex · BioMendics, LLC
- Jul 2027Study on Influencing Factors of Skin Complications Related to Insulin Injection in Children With Type 1 Diabetes Mellitus · The Children's Hospital of Zhejiang University School of Medicine
Who these studies take
Of the 3 Skin Abnormalities studies recruiting now, 3 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 3 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 3 (100%) | 3 (100%) |
| 18 | 3 (100%) | 3 (100%) |
| 30 | 3 (100%) | 3 (100%) |
| 40 | 3 (100%) | 3 (100%) |
| 50 | 3 (100%) | 3 (100%) |
| 65 | 3 (100%) | 3 (100%) |
| 75 | 3 (100%) | 3 (100%) |
| 85 | 3 (100%) | 3 (100%) |
Across all 39 studies, recruiting or not: 44% stop at 75 or younger and 36% at 65; 33% take children; 18% are for women only and 3% for men only; 38% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 12, 2026.
Newly registered1
- Safety and Efficacy of Deoxycholate Treatment of Small Fatty Deformities ( SFD)Oct 19, 2026NCT07880301
Studies
Recruiting first, then most recently updated. Showing 39 of 39. search them.
- A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa SimplexRecruitingNCT07027345Phase 21 country
- Study on Influencing Factors of Skin Complications Related to Insulin Injection in Children With Type 1 Diabetes MellitusNot yet recruitingNCT07615803
- Barrier Functions oF Skin in ICU: SKIN-BARNot yet recruitingNCT075606831 country
- GMEB-SASS: A Gene-Modified Skin Substitute for RDEB TreatmentRecruitingNCT07193134Phase 1/21 country
- A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis BullosaRecruitingNCT06917690Phase 31 country
- Fractional Co2 Laser Versus Microbotox Injection in the Treatment of Wide Facial Pores: A Split Face Comparative StudyNot yet recruitingNCT05923996Phase 1
- Representation of Congenital BirthmarksNot yet recruitingNCT060420751 country
- Safety and Efficacy of Deoxycholate Treatment of Small Fatty Deformities ( SFD)CompletedNCT07880301Phase 41 country
- Apple Peptide Complex for Post-Surgical and Aesthetic Skin RecoveryCompletedNCT07807085Not applicable1 country
- Using an Artificial Intelligence Medical Device to Help Primary Care Practitioners Identify and Manage Skin Conditions (Tumor, Inflammatory, and Infectious Diseases) in Adult Patients at Pozuelo and Majadahonda Health CentersCompletedNCT074291231 country
- Artificial Intelligence Patient App for RDEB SCCsActive, not recruitingNCT058439941 country
- A Pilot Evaluation Exploring New Adhesive Materials and Their Ability to Adhere to Abdominal and Peristomal SkinCompletedNCT05641168Not applicable1 country
- The NEWBORN SKIN ASSESSMENT ATTITUDE SCALECompletedNCT049342541 country
- Assessment of an Innovative Air Mattress on Critically Ill InfantsCompletedNCT06425068Not applicable1 country
- VIO Imaging for Skin Tissue Assessment (VISTA)CompletedNCT05619471Not applicable1 country
- RES Prepared With RECELL® Compared to Conventional Care for Healing of Donor Sites in Ages 1-16 YearsTerminatedNCT03624192Not applicable1 country
- Comparative Study Between CellFX and Electrodessication in Sebaceous Hyperplasia (SH) LesionsCompletedNCT04539886Not applicable1 country
- Nano-Pulse Stimulation (NPS) in Sebaceous HyperplasiaCompletedNCT03612570Not applicable1 country
- Non-Linear Imaging of Skin In VivoCompletedNCT054109641 country
- Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia Optimization StudyTerminatedNCT04253418Not applicable1 country
- Safety and Efficacy of Topical TolaSure Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa SimplexCompletedNCT05062070Phase 11 country
- Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast CancerCompletedNCT014077701 country
- Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis BullosaCompletedNCT03529877Phase 1/25 countries
- An Exploratory Investigation of a Male Focused Skincare SupplementCompletedNCT05319847Not applicable1 country
- How Does Skin Tone Affect Quantitative Photoacoustic ImagingStatus unknownNCT05554523
- Skin Diseases and Pregnancy: Which Heathcare Professionals ?CompletedNCT048138871 country
- Topical and Oral Regimen for Skin HealthCompletedNCT04872946Not applicable1 country
- Hand Sanitizer Effects on the Skin BarrierStatus unknownNCT045255211 country
- Pilot Study of Skin Quality Improvement After Adipose-drived Stem Cell Transfer in Irradiated BreastsWithdrawnNCT01801878Not applicable1 country
- Suprathel Versus Xeroform for the Management of Skin Graft Donor SitesTerminatedNCT04014400Not applicable1 country
- Efficacy of Vinh Wellness Collagen on Skin HealthCompletedNCT04449159Not applicable1 country
- Effects of Bend Beauty's Anti-Aging Formula on Inflammatory MarkersWithdrawnNCT03862872Not applicable1 country
- Change in Skin Elasticity With RF and PEMFCompletedNCT03002194Not applicable1 country
- Efficacy of Polypodium Leucotomos Extract Decreasing UVA Premutagenic and Photoaging MarkersCompletedNCT00520910Phase 21 country
- Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.CompletedNCT00555061Phase 49 countries
- Moisturizing Effect of Two Dexpanthenol FormulationsCompletedNCT00839280Phase 21 country
- Evaluation of Effects of HP828-101 for Moisture Associated Skin DamageTerminatedNCT01108523Early Phase 11 country
- Herbal Therapy for Subcutaneous Injection Site Reactions in Multiple SclerosisCompletedNCT00972062Not applicable1 country
- Safety of Formalin-free Fixatives for In-Vivo Fixation of Skin Lesions.Status unknownNCT01176994Early Phase 11 country